Tonix Pharmaceuticals Holding Corp.
TNXP
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company whose research and development pipeline relies on animal testing. The company’s public disclosures and peer-reviewed publications consistently reference preclinical studies conducted in animal models to support its drug candidates. For example, a 2025 SEC filing notes new data “build upon prior studies showing protection of animals” for one of its development programs.
The company’s work includes developing a potential COVID-19 vaccine using its proprietary horsepox virus platform, a process that necessitates animal testing during preclinical stages. As a clinical-stage pharmaceutical company with no marketed products, its entire value proposition is built upon animal-based research to advance therapies for central nervous system conditions and pain.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.